Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Tuberous Sclerosis 5Seizures 4Marijuana Abuse 3Colonic Neoplasms 3Breast Neoplasms 3Sturge-Weber Syndrome 2Nausea 2Lennox Gastaut Syndrome 2Glioblastoma 2Epilepsies, Myoclonic 2Anxiety Disorders 2Vomiting 1Tuberous Sclerosis 2 1Tuberous Sclerosis 1 1Spasms, Infantile 1Solid Tumor 1Rectal Neoplasms 1Prostatic Neoplasms 1Parasomnias 1Pancreatic Neoplasms 1Pain 1Neoplasms 1Multiple Myeloma 1Liver Neoplasms 1Liver Cirrhosis 1Gallbladder Neoplasms 1Epilepsy 1Dysgeusia 1Drug Resistant Epilepsy 1Colorectal Neoplasms 1

Interventions

Tamoxifen 4Exercise 3pyrotinib 2abemaciclib 2Paclitaxel 2Metformin 2Letrozole 2Cyclophosphamide 2Control Groups 2Capecitabine 2Bupivacaine 2Aromatase Inhibitors 2pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1palbociclib 1iniparib 1exemestane 1durvalumab 1darolutamide 1Yoga 1Waiting Lists 1Vitamin D 1Tretinoin 1Trastuzumab 1Tocopherols 1Thioctic Acid 1Standard of Care 1Sodium Chloride 1Self-Help Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Cancer Female × Cannabidiol × Clear all
NCT05016349 2021-08-23

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

Kafrelsheikh University

Phase 3 Unknown
160 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡